CytoHub

Menu

Accelerating Regenerative Medicine

Empowering Cell & Gene Therapy with AI

with AI

The CytoHub Platform Quadrant

Recent News

Rahul Singhvi, ScD, Co-Founder of National Resilience, joins CytoHub as an Advisor to advance the development of life-saving therapies for patients.

LA JOLLA, Calif.–(BUSINESS WIRE)–CytoHub, Inc., a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, today announced the strategic addition of three top industry experts to its team.

Mohammad El-Kalay, PhD joins CytoHub as an Advisor, brings 35+ years of manufacturing and technical leadership to advance the development of RegenMed.

LA JOLLA, Calif.–(BUSINESS WIRE)–CytoHub, Inc., a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, today announced the strategic addition of three top industry experts to its team.

Richard J. Anderson, Ph.D., joins CytoHub as VP, Technical Operations, brings over 25+ years technical leadership of cellular therapy products.

LA JOLLA, Calif.–(BUSINESS WIRE)–CytoHub, Inc., a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, today announced the strategic addition of three top industry experts to its team.

Aitor Aguirre, Ph.D., Associate Professor at the Department of Biomedical Engineering, MSU joins CytoHub as Co-Founder and Head of R&D.

LA JOLLA, Calif.–(BUSINESS WIRE)–CytoHub, Inc., a pioneering developer of intelligent technologies for cell therapy and regenerative medicine, today announced the strategic addition of three top industry experts to its team.

CardioVive™

Human Mini Heart Technology Platform State-of-the-art cardiac in vitro model Human mini heart with Atrium, Ventricle, Macrophages, Neural Crest, Fibroblasts, and all other cell types emulating 96% of human heart cells..

HeartReady™

Scale-up Solution Powered by AI Optimize process by identifying critical process parameters. Phase appropriate scale-up/down Industry leading expertise and relevant experience

CytoScale™

Scale-up Solution Powered by AI Optimize process by identifying critical process parameters. Phase appropriate scale-up/down Industry leading expertise and relevant experience

BioEngineAI™

Machine Learning-AI Technology Platform – developing and training models using multi-modal datasets to supercharge the development of regenerative medicines